We are live on ! Find out more
DHFB

Dixon Hubard Feinour & Brown Portfolio holdings

AUM $842M
1-Year Est. Return 2.74%
This Fund
S&P 500
This Quarter Est. Return
+3.24%
1 Year Est. Return
-2.74%
3 Year Est. Return
+59.78%
5 Year Est. Return
+118.87%
10 Year Est. Return
–
AUM
$313M
AUM Growth
+$6.96M
Cap. Flow
+$216K
Cap. Flow %
0.07%
Top 10 Hldgs %
24.33%
Holding
174
New
9
Increased
45
Reduced
45
Closed
7

Top Buys

Rank Stock Value
1
TMO icon
Thermo Fisher Scientific
TMO
+$6.44M
2
AVGO icon
Broadcom
AVGO
+$5.8M
3
ADBE icon
Adobe
ADBE
+$5.61M
4
DHR icon
Danaher
DHR
+$4.96M
5
JNJ icon
Johnson & Johnson
JNJ
+$4M

Top Sells

Rank Stock Value
1
NKE icon
Nike
NKE
+$7.38M
2
HRL icon
Hormel Foods
HRL
+$7.04M
3
SBUX icon
Starbucks
SBUX
+$5.83M
4
BA icon
Boeing
BA
+$5M
5
COF icon
Capital One
COF
+$4.02M

Sector Composition

Rank Sector Weight
1 Healthcare 24.67%
2 Industrials 11.4%
3 Technology 10.44%
4 Consumer Staples 8.19%
5 Communication Services 8%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$635B
$9.99M 3.19%
82,350
+35,227
+75% +$4M
XOM icon
2
ExxonMobil
XOM
$651B
$9.09M 2.9%
96,925
-856
-0.9% -$75.7K
HD icon
3
Home Depot
HD
$332B
$8.51M 2.72%
66,623
+495
+0.7% +$65.5K
STZ icon
4
Constellation Brands
STZ
$22.2B
$7.35M 2.35%
44,460
-465
-1% -$72.8K
CVS icon
5
CVS Health
CVS
$137B
$7.03M 2.25%
73,425
-1,522
-2% -$152K
GE icon
6
GE Aerospace
GE
$367B
$6.97M 2.23%
46,185
+276
+0.6% +$40.3K
LMT icon
7
Lockheed Martin
LMT
$134B
$6.92M 2.21%
27,896
-660
-2% -$156K
TFX icon
8
Teleflex
TFX
$5.85B
$6.87M 2.19%
38,745
-300
-0.8% -$48.9K
SYK icon
9
Stryker
SYK
$127B
$6.77M 2.16%
56,523
+100
+0.2% +$11.2K
AAPL icon
10
Apple
AAPL
$4.89T
$6.68M 2.13%
279,404
+11,752
+4% +$292K
META icon
11
Meta Platforms (Facebook)
META
$1.51T
$6.63M 2.12%
57,970
-850
-1% -$97.9K
MSFT icon
12
Microsoft
MSFT
$2.84T
$6.48M 2.07%
126,625
+3,850
+3% +$200K
TMO icon
13
Thermo Fisher Scientific
TMO
$211B
$6.44M 2.06%
+43,610
New +$6.44M
AVGO icon
14
Broadcom
AVGO
$1.82T
$6.42M 2.05%
412,800
+380,800
+1,190% +$5.8M
EW icon
15
Edwards Lifesciences
EW
$47.6B
$6.34M 2.03%
190,827
– –
DHR icon
16
Danaher
DHR
$135B
$5.96M 1.9%
87,772
+75,798
+633% +$4.96M
EMR icon
17
Emerson Electric
EMR
$82.9B
$5.63M 1.8%
108,003
+2,545
+2% +$135K
ADBE icon
18
Adobe
ADBE
$89.5B
$5.59M 1.79%
+58,395
New +$5.61M
BMY icon
19
Bristol-Myers Squibb
BMY
$127B
$5.28M 1.69%
71,816
-1,075
-1% -$76K
DPZ icon
20
Domino's
DPZ
$11B
$5.26M 1.68%
40,040
+970
+2% +$123K
KR icon
21
Kroger
KR
$34.8B
$5M 1.6%
135,990
+350
+0.3% +$12.6K
MHK icon
22
Mohawk Industries
MHK
$6.9B
$4.88M 1.56%
25,737
+665
+3% +$129K
GOOG icon
23
Alphabet (Google) Class C
GOOG
$3.9T
$4.88M 1.56%
141,100
-3,840
-3% -$138K
PFE icon
24
Pfizer
PFE
$140B
$4.73M 1.51%
141,477
-264
-0.2% -$8.43K
ABBV icon
25
AbbVie
ABBV
$458B
$4.72M 1.51%
76,318
+925
+1% +$56.4K
1
2 3 4 5

Similar funds

BDWM
Brewin Dolphin Wealth Management Conskleagh, Dublin, Ireland $917M AUM 12.3% 1-Year Est. Return
MCM
Murphy Capital Management Bedminster, New Jersey $720M AUM 9.22% 1-Year Est. Return
TFM
TPI Fund Managers London, United Kingdom $597M AUM 7.13% 1-Year Est. Return
MWM
Minot Wealth Management Westwood, Massachusetts $389M AUM 3.39% 1-Year Est. Return
CP
Corbenic Partners Bethlehem, Pennsylvania $380M AUM 10.47% 1-Year Est. Return
BWM
BT Wealth Management Atlanta, Georgia $356M AUM 9.63% 1-Year Est. Return
FPS
Fieldpoint Private Securities Greenwich, Connecticut $344M AUM 7.21% 1-Year Est. Return
IC
Intersect Capital San Ramon, California $331M AUM 6.79% 1-Year Est. Return

Dixon Hubard Feinour & Brown's Q2 2016 Portfolio in Review

As of Q2 2016, Dixon Hubard Feinour & Brown held 174 positions worth $313M, up 2.3% from $306M the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Dixon Hubard Feinour & Brown's Q2 2016 filing shows 9 new, 45 increased, 45 reduced and 7 closed positions. Its largest new stake was Thermo Fisher Scientific: 43,610 shares worth $6.44M. The largest sale was Nike, an estimated $7.38M.

By sector, the portfolio is most concentrated in Healthcare at 25% of assets, up from 20% a quarter earlier, followed by Industrials and Technology.

  • Dixon Hubard Feinour & Brown's largest Q2 2016 buy was Thermo Fisher Scientific: 43,610 shares worth $6.44M.
  • Dixon Hubard Feinour & Brown added most to Broadcom in Q2 2016, an estimated $5.8M increase.
  • Dixon Hubard Feinour & Brown's biggest Q2 2016 reduction was Boeing, cutting an estimated $5M.
  • Dixon Hubard Feinour & Brown fully exited Nike in Q2 2016, selling an estimated $7.38M.
  • Dixon Hubard Feinour & Brown's ten largest holdings make up 24% of its $313M portfolio in Q2 2016.
  • Dixon Hubard Feinour & Brown opened 9 new positions and closed 7 in Q2 2016.
  • Dixon Hubard Feinour & Brown's portfolio value rose 2.3% quarter-over-quarter to $313M.

Based on Dixon Hubard Feinour & Brown's 13F filing for Q2 2016, filed 11 Aug 2016.